|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Provision for loan losses | |||||
| Provision for credit losses | |||||
| Share-based compensation expense | |||||
| Loans originated for sale | |||||
| Proceeds from sale of loans originated for sale | |||||
| Loss (gain) on sale of loans | |||||
| Loss (gain) on sale of other real estate owned | |||||
| Decrease in fair value of loans held-for-sale | |||||
| Loss (gain) on derivatives | |||||
| Gain on prepayment of FHLB advances | |||||
| Gain on termination of interest rate swaps | |||||
| Gain on sale of premises and equipment | |||||
| Net change in servicing asset | |||||
| Net deferred income tax | |||||
| Net change in other assets | |||||
| Net change in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Net loan activity, excluding sales and purchases | |||||
| Proceeds from sales of other real estate owned | |||||
| Net proceeds from sales of portfolio loans | |||||
| Maturities of securities available-for-sale | |||||
| Purchase of securities available-for-sale | |||||
| Maturities and calls of securities held-to-maturity | |||||
| Purchase of securities held-to-maturity | |||||
| Redemption of Federal Home Loan Bank of Indianapolis stock | |||||
| Net proceeds from sale of premises and equipment | |||||
| Purchase of Federal Home Loan Bank of Indianapolis stock | |||||
| Proceeds from bank owned life insurance | |||||
| Purchase of premises and equipment | |||||
| Loans purchased | |||||
| Purchase of equity investments | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net (decrease) increase in deposits | |||||
| Cash dividends paid | |||||
| Net proceeds from issuance of subordinated debt | |||||
| Repayment of subordinated debt | |||||
| Repurchase of common stock | |||||
| Proceeds from advances from Federal Home Loan Bank | |||||
| Repayment of advances from Federal Home Loan Bank | |||||
| Other, net | |||||
| Net cash used in by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosures of cash flows information | |||||
| Cash paid during the year for interest | |||||
| Cash paid during the year for taxes | |||||
| Loan transferred to equity investment | |||||
| Loans transferred to other real estate owned | |||||
| Loans transferred to held-for-sale from portfolio | |||||
| Cash dividends declared, not paid | |||||
| Securities purchases settled in subsequent period | |||||
| Transfer of available-for-sale mortgage-backed securities to held-to-maturity mortgage-backed securities at fair value | |||||
Loading...
